The FINANCIAL -- Novo Nordisk is investing 1.5 billion Danish kroner in a new 7,500 m2 facility in Kalundborg, Denmark. The facility will produce active pharmaceutical ingredients for NovoSeven and future products for treating ...
The FINANCIAL -- Sanofi Chief Executive Officer, Olivier Brandicourt commented:"Sanofi had a good start to 2015. Our businesses provide a solid foundation for our new-product cycle. Sanofi's recent ...
The FINANCIAL -- A quarter of countries that responded to a WHO survey have national plans to preserve antimicrobial medicines like antibiotics, but many more countries must also step up. A new ...
The FINANCIAL -- Bristol-Myers Squibb Company on April 29 announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application ...
The FINANCIAL -- AstraZeneca on April 29 announced that the US Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) and granted Priority Review for BRILINTA ...
The FINANCIAL -- Gilead Sciences, Inc. announced on April 30 its results of operations for the first quarter ended March 31, 2015. The financial results that follow represent a year over year ...
The FINANCIAL -- GlaxoSmithKline plc and Theravance, Inc. on April 30 announced that the US Food and Drug Administration (FDA) has approved BREO ELLIPTA (fluticasone furoate/vilantero for the ...
The FINANCIAL -- Women account for nearly 60 percent of visits to emergency departments (ED) in the United States. In emergency situations, it is critical for doctors to know the pregnancy status of ...
The FINANCIAL -- The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released on April 29 a new report on antimicrobial resistance (AMR) calling for a global ...